Transfection Technologies Market to Reach $1.8 Billion by 2028 Due to Advances in Cell Biology R&D and Demand for Innovative Therapeutics

• Global transfection technologies market to reach $1.8 billion by 2028, growing at a 9.4% CAGR from an estimated $1.2 billion in 2023 • Kits and reagents dominated the market in 2022 due to increasing demand for high-quality reagents for efficient nucleic acid delivery • North America led the market in 2022 thanks to strong academic/research networks and investments in biologics and advanced therapeutics • Key growth drivers include advances in physical methods, R&D in cell biology, personalized medicine, and demand for cutting-edge therapeutics • Major players operating in the market include Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Merck KGaA, and Sartorius AG